Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Urine Biomarker Test Can Diagnose, Predict Rejection of Transplanted Kidneys
Uncategorized

Urine Biomarker Test Can Diagnose, Predict Rejection of Transplanted Kidneys

By Roger AndersonAug 9, 2013
Share
Facebook Twitter Email
John Friedewald, MD, associate professor in medicine-nephrology and surgery-organ transplantation, at left, and Michael Abecassis, MD, MBA, director of the Comprehensive Transplant Center and chief of surgery-organ transplantation, were among the authors of a New England Journal of Medicine publication outlining a urine biomarker test that can diagnose and predict rejection of transplanted kidneys.

By measuring just three genetic molecules in a urine sample, scientists were able to detect whether transplanted kidneys were in the process of being rejected, as well as identify patients at risk for rejection weeks to months before showing symptoms. 

The study, published in The New England Journal of Medicine, was co-authored by 25 investigators from across the country, including John Friedewald, MD, associate professor in medicine-nephrology and surgery-organ transplantation, and Michael Abecassis, MD, MBA, director of the Comprehensive Transplant Center and chief of surgery-organ transplantation. 

The urine test accurately diagnoses acute rejection of kidney transplants, the most frequent and serious complication for this surgery, and may help physicians fine-tune the amount of powerful immunosuppressive drugs that organ transplant patients must take for the rest of their lives.

The clinical trial began in 2006 with participation from five medical centers, including Northwestern University Feinberg School of Medicine, which contributed the most transplant patients. 

Researchers collected 4,300 urine specimens during the first year of transplantation, starting three days after surgery. Analysis of the samples revealed the accuracy of the three-gene biomarker. The scientists used biopsy to confirm rejection.

 “Our work on this trial led to our being funded in the next round of Clinical Trials in Organ Transplants funding,” Friedewald said.  “We currently are the lead site on two similar trials and are in the process of enrolling 300 kidney and liver patients to advance the findings from the recently published results.”

In those trials, Feinberg scientists will look at blood and biopsy tissue in addition to urine samples for improved biomarkers of rejection and other problems in kidney and liver transplant recipients. 

“The hope of the current publication and our ongoing National Institutes of Health-funded research is to improve non-invasive testing for transplant recipients and to be able to better individualize therapy for our patients,” Friedewald said.

The New England Journal of Medicine study was supported by NIH grants UO1AI63589 and R37AI051652, the Qatar National Research Foundation (NPRP 08-503-3-111) and by a Clinical and Translational Science Center Award (UL1TR000457, to Weill Cornell Medical College). From September 2004 through August 2011, Northwestern was a consortium site on the U01 AI063589 grant.

Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.